Trial Profile
Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2023
Price :
$35
*
At a glance
- Drugs Tenecteplase (Primary) ; Alteplase
- Indications Stroke
- Focus Therapeutic Use
- Acronyms EXTEND-IA TNK
- 06 Mar 2023 Results of pooled post hoc analysis (n=71, EXTEND-IA TNK trials) assessing safety and efficacy of tenecteplase in patients with tandem lesion stroke published in the Neurology
- 10 Feb 2023 Results assessing the reperfusion efficacy of tenecteplase and alteplase in subgroups based on these characteristics in a pooled analysis of the EXTEND-IA TNK trials, presented at the International Stroke Conference 2023
- 02 Feb 2023 Results of pooled analysis from EXTEND-IA TNK trials assessing reperfusion efficacy of tenecteplase and alteplase in subgroups based on these characteristics published in the Stroke